美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
65219-592-10	65219-592	HUMAN PRESCRIPTION DRUG	TYENNE	Tocilizumab-aazg	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20240415	N/A	BLA	BLA761275	Fresenius Kabi USA, LLC	TOCILIZUMAB	200 mg/10mL	1 VIAL, SINGLE-DOSE in 1 CARTON (65219-592-10) / 10 mL in 1 VIAL, SINGLE-DOSE
65219-594-20	65219-594	HUMAN PRESCRIPTION DRUG	TYENNE	Tocilizumab-aazg	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20240415	N/A	BLA	BLA761275	Fresenius Kabi USA, LLC	TOCILIZUMAB	400 mg/20mL	1 VIAL, SINGLE-DOSE in 1 CARTON (65219-594-20) / 20 mL in 1 VIAL, SINGLE-DOSE
65219-590-04	65219-590	HUMAN PRESCRIPTION DRUG	TYENNE	Tocilizumab-aazg	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20240415	N/A	BLA	BLA761275	Fresenius Kabi USA, LLC	TOCILIZUMAB	80 mg/4mL	1 VIAL, SINGLE-DOSE in 1 CARTON (65219-590-04) / 4 mL in 1 VIAL, SINGLE-DOSE
65219-586-04	65219-586	HUMAN PRESCRIPTION DRUG	TYENNE	Tocilizumab-aazg	INJECTION, SOLUTION	SUBCUTANEOUS	20240701	N/A	BLA	BLA761275	Fresenius Kabi USA, LLC	TOCILIZUMAB	162 mg/.9mL	1 SYRINGE, GLASS in 1 CARTON (65219-586-04) / .9 mL in 1 SYRINGE, GLASS
65219-584-01	65219-584	HUMAN PRESCRIPTION DRUG	TYENNE	Tocilizumab-aazg	INJECTION, SOLUTION	SUBCUTANEOUS	20240701	N/A	BLA	BLA761275	Fresenius Kabi USA, LLC	TOCILIZUMAB	162 mg/.9mL	1 SYRINGE, GLASS in 1 CARTON (65219-584-01) / .9 mL in 1 SYRINGE, GLASS